Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cheek cells could reverse blindness in rare eye condition

NCT ID NCT03949881

First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 19 times

Summary

This study tests a new way to treat total blindness caused by severe eye burns or rare diseases that destroy the eye's surface stem cells. Doctors take a small sample of cells from the patient's cheek, grow them into a thin sheet in the lab, and transplant it onto the eye to restore a clear surface. The trial includes 40 adults in France and aims to see if the procedure is safe and can improve vision.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TOTAL BILATERAL LIMBAL CELL DEFICIENCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ophthalmology department, Edouard Herriot hospital, Hospices Civils de Lyon

    RECRUITING

    Lyon, 69003, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.